Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$225.07 - $246.17 $5,626 - $6,154
-25 Reduced 1.84%
1,331 $311,000
Q2 2023

Jul 20, 2023

BUY
$238.39 - $265.32 $3,575 - $3,979
15 Added 1.12%
1,356 $357,000
Q1 2023

May 01, 2023

SELL
$229.71 - $259.35 $6,891 - $7,780
-30 Reduced 2.19%
1,341 $331,000
Q4 2022

Jan 23, 2023

BUY
$218.29 - $256.91 $4,365 - $5,138
20 Added 1.48%
1,371 $0
Q2 2022

Jul 25, 2022

SELL
$234.74 - $275.42 $4,694 - $5,508
-20 Reduced 1.46%
1,351 $333,000
Q1 2022

May 03, 2022

SELL
$243.64 - $270.48 $5,603 - $6,221
-23 Reduced 1.65%
1,371 $365,000
Q3 2021

Nov 01, 2021

SELL
$232.72 - $256.47 $32,813 - $36,162
-141 Reduced 9.19%
1,394 $343,000
Q2 2021

Aug 05, 2021

BUY
$232.65 - $254.58 $2,326 - $2,545
10 Added 0.66%
1,535 $373,000
Q4 2020

Jan 20, 2021

BUY
$221.92 - $245.94 $3,106 - $3,443
14 Added 0.93%
1,525 $382,000
Q3 2020

Oct 15, 2020

BUY
$215.77 - $276.76 $129,030 - $165,502
598 Added 65.5%
1,511 $352,000
Q2 2020

Aug 03, 2020

BUY
$219.9 - $263.41 $200,768 - $240,493
913 New
913 $218,000
Q3 2019

Oct 11, 2019

SELL
$230.58 - $256.08 $219,973 - $244,300
-954 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$217.4 - $246.08 $10,870 - $12,304
-50 Reduced 4.98%
954 $240,000
Q1 2019

May 07, 2019

BUY
$206.05 - $248.17 $206,874 - $249,162
1,004 New
1,004 $251,000
Q4 2018

Feb 07, 2019

SELL
$204.73 - $257.93 $201,659 - $254,061
-985 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $233 - $256
1 Added 0.1%
985 $255,000
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $204,770 - $230,108
984 New
984 $235,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Measured Wealth Private Client Group, LLC Portfolio

Follow Measured Wealth Private Client Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.